Published in Clin Exp Immunol on May 01, 2000
Antiphospholipid syndrome infectious origin. J Clin Immunol (2004) 1.00
Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies. Hippokratia (2008) 0.89
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol (2005) 0.88
The mosaic of "seronegative" antiphospholipid syndrome. J Immunol Res (2014) 0.87
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res Ther (2006) 0.84
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. J Immunol Res (2015) 0.78
Characterization of antiphospholipid antibodies in chronic hepatitis B infection. Korean J Hematol (2011) 0.75
Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction. Semin Immunol (2011) 0.75
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. Nat Rev Rheumatol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A (1990) 4.59
Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood (1994) 2.66
Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology (1996) 2.47
Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.75
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med (1994) 1.74
Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis (1997) 1.66
The anticardiolipin syndrome. Clin Exp Rheumatol (1986) 1.53
Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol (1992) 1.47
Anticardiolipin response in acute infections. Clin Immunol Immunopathol (1986) 1.39
Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem (1994) 1.27
Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clin Exp Immunol (1989) 1.12
Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis (1988) 1.06
Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost (1995) 1.04
Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis (1994) 1.02
Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol (1997) 1.02
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface. Thromb Haemost (1995) 0.98
Autoimmunity to cardiolipin in infectious mononucleosis. Lancet (1987) 0.97
Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem Biophys Res Commun (1994) 0.94
Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost (1996) 0.92
Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost (1996) 0.92
Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1996) 0.91
Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods (1994) 0.89
Anti-cardiolipin antibodies in viral infection. Lancet (1989) 0.87
Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost (1996) 0.87
Protein S deficiency and antibodies to protein S in patients with Behçet's disease. Thromb Res (1997) 0.86
Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost (1997) 0.85
Protein S antibodies in acquired protein S deficiencies. Blood (1994) 0.85
Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med (1992) 0.83
Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol (1998) 0.81
Anticardiolipin antibodies in leptospirosis. J Clin Pathol (1991) 0.81
Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency. Thromb Haemost (1996) 0.80
Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol (1995) 0.80
Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity. Biochim Biophys Acta (1999) 0.80
Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemost (1995) 0.79
Anticardiolipin antibodies and Pneumocystis carinii pneumonia. Ann Intern Med (1989) 0.78
Effective inhibition of cardiolipin-binding antibodies in gram-negative infections by bacterial lipopolysaccharide. Scand J Immunol (1988) 0.78
Anti-phospholipid antibody profiles of different specificities in syphilis and systemic lupus erythematosus. Immunol Invest (1991) 0.77
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis (2010) 2.40
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med (1995) 2.07
Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol (2012) 2.02
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis (2004) 1.80
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol (2006) 1.54
Helicobacter pylori diagnosis in patients with liver cirrhosis. Dig Liver Dis (2003) 1.49
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum (2005) 1.49
Cardiac involvement in Behçet's disease. Cardiology (1998) 1.42
Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ (2004) 1.42
Do Behçet's syndrome patients with acne and arthritis comprise a true subset? Comment on the article by Hatemi et al. Arthritis Rheum (2009) 1.40
Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med (1998) 1.34
IgG subclasses in human hydatid disease: prominence of the IgG4 response. Int Arch Allergy Immunol (1993) 1.22
Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol (2010) 1.21
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol (2004) 1.16
Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int (2000) 1.14
Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol (2000) 1.11
Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol (1985) 1.10
Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab (1995) 1.09
Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology (1998) 1.09
Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol (1997) 1.09
Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis (2006) 1.08
Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS). J Endocrinol Invest (2001) 1.07
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost (1990) 1.07
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun (1994) 1.06
Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis (2005) 1.04
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol (2003) 1.04
Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells. Cell Death Differ (2005) 1.03
Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ (2010) 1.01
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis (2002) 0.99
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford) (2008) 0.98
Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus (1993) 0.97
Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood (2000) 0.96
Ultrasound imaging for the rheumatologist. XXIV. Sonographic evaluation of wrist and hand joint and tendon involvement in systemic lupus erythematosus. Clin Exp Rheumatol (2010) 0.96
Evidence for shared epitopes between cardiolipin and Pneumocystis carinii. J Infect Dis (1989) 0.95
Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol (1996) 0.95
Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.94
Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies. Clin Exp Immunol (1985) 0.94
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus (1995) 0.93
Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis (2010) 0.93
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. BMJ (1990) 0.92
Polymorphism and deficiency of human factor H-related proteins p39 and p37. Immunogenetics (1992) 0.91
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis (2008) 0.91
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis (2008) 0.90
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol (2015) 0.90
Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus. Lupus (1993) 0.90
Sonography in the study of metatarsalgia. J Rheumatol (2001) 0.90
New radiopharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med Mol Imaging (2006) 0.90
Ultrasound imaging for the rheumatologist II. Ultrasonography of the hand and wrist. Clin Exp Rheumatol (2006) 0.90
Ultrasound imaging for the rheumatologist VII. Ultrasound imaging in rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.89
Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. Thromb Res (1994) 0.89
Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods (1994) 0.89
Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis. Ann Rheum Dis (2008) 0.88
Markers of vascular injury in Behçet's disease associated with retinal vasculitis. Ann Ophthalmol (1992) 0.88
Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol (1999) 0.88
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol (2005) 0.88
Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy. Rheumatology (Oxford) (2008) 0.88
Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in SupT1 lymphoblastoid cells. FEBS Lett (2001) 0.88
Circulating immune complexes in sera of patients infected with Echinococcus granulosus. Clin Exp Immunol (1983) 0.88
Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies. Clin Exp Immunol (1981) 0.88
Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis (2005) 0.88
A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase c delta translocation. J Biol Chem (1998) 0.87
GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett (2001) 0.87
Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci (1998) 0.87
Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori (1986) 0.87
Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Clin Rheumatol (2003) 0.87
Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost (1996) 0.87
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann Ist Super Sanita (1999) 0.87
Ultrasound imaging for the rheumatologist. XXXII. Sonographic assessment of the foot in patients with psoriatic arthritis. Clin Exp Rheumatol (2011) 0.87
Ultrasound imaging for the rheumatologist. XX. Sonographic assessment of hand and wrist joint involvement in rheumatoid arthritis: comparison between two- and three-dimensional ultrasonography. Clin Exp Rheumatol (2009) 0.86
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus (2005) 0.86
Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood (1997) 0.86
Ultrasound imaging for the rheumatologist VIII. Ultrasound imaging in osteoarthritis. Clin Exp Rheumatol (2007) 0.86
Role of autoimmunity in protein S deficiency during HIV-1 infection. Infection (1994) 0.86
Conductometric properties of human erythrocyte membranes: dependence on haematocrit and alkali metal ions of the suspending medium. Eur Biophys J (1997) 0.86
Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann N Y Acad Sci (2010) 0.86
Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol (2008) 0.85
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus (2003) 0.85
Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a single center, observational study over an 8-year period. Clin Exp Rheumatol (2009) 0.85
Protein S antibodies in acquired protein S deficiencies. Blood (1994) 0.85
Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol (2010) 0.85
Risk factors for Sjögren's syndrome: a case-control study. Clin Exp Rheumatol (2007) 0.85
Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun (1998) 0.85
Y chromosome microchimerism in Sjögren's syndrome. Ann Rheum Dis (2001) 0.85
Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis. Clin Exp Immunol (2004) 0.84
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis (2008) 0.84